EMEA-002986-PIP01-21

Key facts

Active substance
Zorecimeran
Therapeutic area
Vaccines
Decision number
P/0212/2021
PIP number
EMEA-002986-PIP01-21
Pharmaceutical form(s)
Concentrate and solvent for dispersion for injection
Condition(s) / indication(s)
Prevention of Coronavirus disease 2019 (COVID-19)
Route(s) of administration
Intramuscular use
Contact for public enquiries
CureVac AG

Tel.  +49 7071 9880-0
E-mail: info@curevac.com

Decision type
P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s)

Decision

How useful was this page?

Add your rating
Average
1 rating
2 ratings
1 rating
3 ratings